Vaccination in the immunotherapy of glioblastoma
Glioblastoma remains one of the most common central nervous system tumors with an extremely poor prognosis. Recently, rapid progress in immunotherapy has provided new options for the treatment of glioblastoma. Vaccination, the primary method of immunotherapy, stimulates the body's tumor-specifi...
Saved in:
Main Authors: | Ziren Kong (Author), Yu Wang (Author), Wenbin Ma (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential
by: Tianrui Yang, et al.
Published: (2021) -
Immunotherapy of glioblastoma: Recent advances and future prospects
by: Boyang Yuan, et al.
Published: (2022) -
Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C
by: Ping Zhu, et al.
Published: (2023) -
Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme
by: Giannis Sokratous, et al.
Published: (2017) -
Dual-targeting prodrug nanotheranostics for NIR-Ⅱ fluorescence imaging-guided photo-immunotherapy of glioblastoma
by: Fenglin Li, et al.
Published: (2022)